- Report
- October 2024
- 182 Pages
Global
From €3245EUR$3,545USD£2,758GBP
€3606EUR$3,939USD£3,064GBP
- Report
- April 2025
- 200 Pages
Global
From €4110EUR$4,490USD£3,493GBP
- Report
- May 2025
- 196 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1831EUR$2,000USD£1,556GBP
- Drug Pipelines
- April 2025
- 80 Pages
Global
From €1831EUR$2,000USD£1,556GBP
- Drug Pipelines
- July 2024
- 150 Pages
Global
From €3433EUR$3,750USD£2,917GBP
- Report
- February 2025
- 186 Pages
Global
From €4119EUR$4,500USD£3,501GBP
- Report
- December 2023
- 130 Pages
Global
From €5447EUR$5,950USD£4,629GBP
- Report
- May 2024
- 136 Pages
Global
From €5949EUR$6,499USD£5,056GBP
- Report
- May 2024
- 133 Pages
Global
From €5949EUR$6,499USD£5,056GBP
- Report
- August 2022
- 117 Pages
Global
From €4119EUR$4,500USD£3,501GBP
- Report
- April 2023
- 147 Pages
Global
From €4530EUR$4,949USD£3,850GBP
- Report
- November 2022
- 191 Pages
From €3158EUR$3,450USD£2,684GBP
- Report
- November 2022
- 210 Pages
Asia Pacific
From €3158EUR$3,450USD£2,684GBP
- Report
- November 2022
- 222 Pages
Europe
From €3158EUR$3,450USD£2,684GBP
- Report
- November 2022
- 197 Pages
Middle East, Africa
From €3158EUR$3,450USD£2,684GBP
- Report
- November 2022
- 193 Pages
North America
From €3158EUR$3,450USD£2,684GBP
- Report
- August 2022
- 330 Pages
Global
From €4074EUR$4,450USD£3,462GBP
- Report
- September 2024
- 80 Pages
Japan
From €3204EUR$3,500USD£2,723GBP
- Report
- February 2024
- 102 Pages
Global
From €3500EUR$4,096USD£3,079GBP

Zanamivir is an antiviral drug used to treat infections caused by influenza A and B viruses. It is a neuraminidase inhibitor, meaning it works by blocking the activity of the influenza virus enzyme neuraminidase, which is essential for the virus to spread within the body. Zanamivir is administered through inhalation and is available in both capsule and powder form. It is typically used to treat acute uncomplicated influenza in adults and children over the age of five.
Zanamivir is one of several drugs used to treat infectious diseases, and is often used in combination with other drugs to increase its effectiveness. It is generally well-tolerated, with few side effects. However, it is not effective against all strains of influenza, and resistance to the drug has been reported in some cases.
The zanamivir market is highly competitive, with several major pharmaceutical companies producing and marketing the drug. These include GlaxoSmithKline, Novartis, Sanofi, and Daiichi Sankyo. Show Less Read more